Clinical Trials on Cancer Risk in Finland
Total 1314 results
-
Brown UniversityAstraZeneca; The Miriam Hospital; Rhode Island HospitalTerminatedProstate Cancer | Adenocarcinoma of the ProstateUnited States
-
howard safranBrown University; Lifespan; Novartis Pharmaceuticals Corporation (Financial supporter)TerminatedRectal CancerUnited States
-
Roger Williams Medical CenterTerminated
-
Tampere UniversityCompletedProstate CancerFinland, Ireland, Sweden
-
Roger Williams Medical CenterSuspendedTrial of Anti-PSMA Designer T Cells in Advanced Prostate Cancer After Non-Myeloablative ConditioningMonitor Adverse EventsUnited States
-
Brown UniversityTerminatedMelanoma | Prostate Cancer | Renal CancerUnited States
-
Women and Infants Hospital of Rhode IslandTerminatedBreast Cancer | Ovarian CancerUnited States
-
Brown UniversityBristol-Myers Squibb; The Miriam Hospital; Rhode Island Hospital; Women and Infants...Terminated
-
Brown UniversityUniversity of Maryland Greenebaum Cancer CenterCompletedEsophageal CancerUnited States
-
Eli Lilly and CompanyCompletedCancer | Solid TumorUnited States
-
Women and Infants Hospital of Rhode IslandCompletedVulvar CancerUnited States
-
Women and Infants Hospital of Rhode IslandCompletedBreast Cancer | Hot FlashesUnited States
-
Brown UniversityThe Miriam Hospital; Rhode Island Hospital; Memorial Hospital of Rhode Island; Women... and other collaboratorsTerminatedTrial of Chemotherapy and Avastin as Treatment for Women With Breast Cancer at High Risk for RelapseBreast CancerUnited States
-
Dr Thomas DiPetrilloMemorial Hospital of Rhode IslandCompletedLung CancerUnited States
-
Dana-Farber Cancer InstituteCompletedOther CancerUnited States
-
Dana-Farber Cancer InstituteAmbry GeneticsCompletedBreast Cancer | Pancreatic Cancer | Ovarian Cancer | Metastatic Prostate CancerUnited States
-
Brown UniversityCompletedPancreatic CancerUnited States
-
University of NebraskaNational Cancer Institute (NCI)CompletedRecurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung CancerUnited States
-
Allarity TherapeuticsRecruitingMetastatic Breast CancerGermany, Finland, Poland, United Kingdom, Belgium, Italy, Netherlands
-
MedImmune LLCCompletedCancer | Solid TumorsUnited States, Spain
-
William Sikov MDYale UniversityCompletedBreast CancerUnited States
-
Dana-Farber Cancer InstituteSusan G. Komen Breast Cancer FoundationRecruiting
-
Jaroslaw HepelThe Miriam Hospital; Rhode Island HospitalCompletedBreast CancerUnited States
-
BioTex, Inc.Rhode Island HospitalCompletedThyroid Neoplasms | Nodular Goiter | Thyroid Cancer | Thyroid NoduleUnited States
-
BayerCompletedAdvanced Recurrent Malignant Pleural Epithelioid Mesothelioma | Advanced Recurrent Malignant Peritoneal Epithelioid Mesothelioma | Advanced Recurrent Serous Ovarian Cancer | Advanced Pancreatic Ductal Adenocarcinoma (Optional, Dose Expansion, Not Initiated)United States, Sweden, Netherlands, United Kingdom, Finland
-
Side-Out FoundationTranslational Drug DevelopmentCompleted
-
Bristol-Myers SquibbCompletedHigh Risk Stage III MelanomaItaly, Poland, United Kingdom, United States, Netherlands, Spain, Australia, France, Germany, Canada, Russian Federation, Belgium, Norway, Switzerland, Sweden, Finland, Austria, Denmark, Czechia
-
William Sikov MDYale UniversityCompletedBreast CancerUnited States
-
VA Office of Research and DevelopmentCompleted
-
Hoffmann-La RocheCompletedBreast CancerAustralia, Spain, United Kingdom, Germany, Belgium, Italy, Finland, Netherlands
-
Gulam ManjiRegeneron Pharmaceuticals; BioLine RxRecruitingAdenocarcinoma | Pancreatic Cancer | Adenocarcinoma of the PancreasUnited States
-
Ohio State UniversityPatient-Centered Outcomes Research Institute; The George Washington University...Not yet recruitingPregnancy, High Risk | Gestational Diabetes MellitusUnited States
-
Nordic Society of Gynaecological Oncology - Clinical...European Network of Gynaecological Oncological Trial Groups (ENGOT); Gynecologic...Completed
-
Brown UniversityPfizer; LifespanTerminatedOvarian Cancer | Fallopian Tube Cancer | BRCA1 Mutation | BRCA2 Mutation | High Grade Serous CarcinomaUnited States
-
Orion Corporation, Orion PharmaActive, not recruitingProstate Cancer MetastaticFrance, United Kingdom, Finland, United States
-
Brown UniversityThe Miriam HospitalCompletedProstate CancerUnited States
-
Dartmouth-Hitchcock Medical CenterNational Institute of Nursing Research (NINR)Completed
-
Chinese University of Hong KongChangi General Hospital; University Hospital AugsburgRecruitingColorectal Neoplasms | Colorectal Cancer | AdenomaHong Kong
-
ImunonTerminatedColon Cancer Liver MetastasisUnited States
-
Brown UniversityThe Miriam Hospital; Rhode Island HospitalTerminatedAnal CancerUnited States
-
MacroGenicsRecruitingProstate Cancer Recurrent | Immunotherapy | Androgen-Independent Prostatic Cancer | Androgen-Resistant Prostatic Cancer | Hormone Refractory Prostatic Cancer | Immune Checkpoint Inhibitor | Androgen-Independent Prostatic Neoplasms | Androgen-Insensitive Prostatic Cance | Inhibitory Checkpoint MoleculeUnited States, Spain, France, Belgium, United Kingdom, Poland, Georgia, Bulgaria, Puerto Rico, Australia
-
Medical Diagnostic Laboratories, LLCUnknownBladder Cancer | Hematuria | DysuriaUnited States
-
Cancer Trials IrelandCompletedMetastatic Breast CancerSpain, Ireland, Israel, Finland, Portugal, France, Germany, Norway
-
Brown UniversityBristol-Myers Squibb; The Miriam Hospital; Rhode Island Hospital; Women and Infants...Active, not recruitingOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Carcinoma | Extra Renal Origin | Clear Cell AdenocarcinomaUnited States
-
Hoffmann-La RocheRecruitingBreast CancerBelgium, Spain, Finland, Italy, Germany, Denmark
-
University of New BrunswickQuebec Breast Cancer Foundation; UltramarUnknown
-
Gustave Roussy, Cancer Campus, Grand ParisRecruitingHigh-Risk Neuroblastoma | Patient With Insufficient Response ChemoimmunotherapyFrance, Germany, Israel, Spain, United Kingdom, Belgium, Norway, Sweden, Finland, Australia, Czechia, Italy, Netherlands, Slovenia, Switzerland, Denmark, Greece, Lithuania, Slovakia
-
Women and Infants Hospital of Rhode IslandCompletedOvarian Cancer | brca1 Mutation Carrier | brca2 Mutation CarrierUnited States